Day: March 17, 2022

As of Mar 17, over 5.4 million people, representing 73.7% of population in the country, have been vaccinated with at least one dose of the Covid-19 vaccine, according to the Centre of Information and Education for Health, Ministry of Health.
Meanwhile, the number of people fully vaccinated against Covid-19 currently stands at 4.39 million people, accounting for 59.9% of the population, and those given a booster has shared 14.3% of the population.
Some 874 people have been diagnosed with Covid-19 over the past twenty-four hours, the National Taskforce Committee for Covid-19 Prevention and Control told a press conference today.
The newly confirmed cases included 855 cases classified as domestic infections with 437 documented in Vientiane, 143 in Savannakhet, 69 in Xieng Khuang, 30 in Huaphan and 27 in Vientiane (province).
Since late March 2020, the total caseload in the country has reached 149,131 including 1,349 active cases and 643 deaths.

Source: Lao News Agency

The 3rd Lancang-Mekong Business Forum (LMBF) on “Promoting Agribusiness and Investment in Processed Food Sector” will be held from Mar 30-31 in Phnom Penh, Cambodia.
The Business Forum is part of a long-term project funded by the Lancang-Mekong Cooperation Special Fund (LMCSF) of P. R. China and has been organized by Mekong Institute (MI) in each of Lancang-Mekong (LM) countries, namely Cambodia, P.R. China, the Lao PDR, Myanmar, Vietnam and Thailand, since 2018 in coordination with the Ministry of Commerce of Thailand.
In 2022, Mekong Institute collaborates with Cambodia Chamber of Commerce to co-organize the 3rd LMBF in order to promote agribusiness and processed food sector of Cambodia and LM countries.
Exchange business information and market opportunities in agro-food processing sector in the Lancang-Mekong countries are one of the objectives of the forum.

Source: Lao News Agency

The Government of Japan has provided US$19.4 million to improve facilities and laboratory equipment of the Faculty of Engineering, National University of Laos.
An agreement on the funding from the Japanese government was signed at the Ministry of Foreign Affairs in Vientiane on Mar 15.
The agreement was signed by Deputy Minister of Foreign Affairs Mr Phoxay Khaykhamphithoune and the Japanese Ambassador to the Lao PDR, Mr Kenichi Kobayashi.
The assistance is part of a programme to assist Laos which was announced by Japan’s Prime Minister Kishida Fumio during telephone talks with Lao Prime Minister Phankham Viphavanh on Mar 1.
The funding demonstrates Japan’s commitment to supporting Laos’ priorities including its 9th National Socio-Economic Development Plan 2021-2025.
The project aims to upgrade the quality and capacity of human resources to international standards, and to meet the current demands of labour market.
Addressing the signing ceremony, Mr Phoxay expressed his gratitude and appreciation for the cooperation and assistance of the government and people of Japan, saying it is a significant contribution to the development of Laos, especially to improving the living standards of Lao people.
Ambassador Kobayashi also pledged to continue to work with Laos to promote the long-standing friendly relations and cooperation between the two countries.

Source: Lao News Agency

Minister of Information, Culture and Tourism Suansavanh Viyaketh visited on Mar 16 Champassak to monitor the progress of a road construction project under the Greater Mekong Subregion (GMS) Tourism Infrastructure for Inclusive Growth Project.
Conducted by local company Phu Khong Construction, the infrastructure development project is funded by a US$4 million grant from the Asian Development Bank (ADB).
The project involves the improvement of roads in Nakasang and Don Det-Don Khone in Khong district, Champassak.
Scheduled to be completed within 24 months, from May 26, 2020 to May 20, 2022, the project, due to Covid-19, has achieved only 66.9% of its plan.
Once completed, the project will facilitate the transportation of local people as well as domestic and foreign tourists to and from tourist attractions in the southernmost province.

Source: Lao News Agency

Moderna Inc sought emergency use authorization with U.S. health regulators for a second COVID-19 booster shot late Thursday, as a surge in cases in some parts of the world fuels fears of another wave of the pandemic.
The U.S. biotechnology company said its request covered all adults over the age of 18 so that the appropriate use of an additional booster dose of its vaccine, including for those at higher risk of COVID-19 due to age or comorbidities, could be determined by the U.S. Centers for Disease Control and Prevention (CDC) and health care providers.
Moderna’s request is significantly broader than Pfizer Inc and its German partner BioNTech SE’s application that was filed earlier this week with U.S. regulators for a second booster shot for people aged 65 and older.
Moderna, without specifically commenting on the effectiveness of a fourth shot, said its submission was partly based on data recently published in the United States and Israel following the emergence of the omicron variant.
FDA did not immediately respond to a Reuters request for comment.
U.S. health officials, including top infectious disease expert Dr. Anthony Fauci, have raised the prospect of a fourth shot, especially for older people and to prepare for the possibility of another surge in cases.
CDC data has shown that vaccine efficacy wanes over time and a third shot helps restore it. It, however, has not released comprehensive data based on age or health status to back the case.
The news was first reported by The New York Times.
While COVID-19 cases are falling in the United States and much of the world, infections are rising in China. In the UK and Europe, there has been a reversal in the downward trend of COVID cases as economies have opened up and a second variant of omicron circulates.

Source: Voice of America

Conservative Republican lawmakers on Thursday revived a proposal to weaken Kansas’ vaccination requirements for children enrolling in school and day care and to make it easier for people to get potentially dangerous treatments for COVID-19.
The Senate health committee approved a bill that would allow parents to get a no-questions-asked religious exemption from requirements to vaccinate their children against more than a dozen diseases, including measles, whooping cough, polio and chickenpox.
The measure also would limit pharmacists’ ability to refuse to fill prescriptions for the anti-worm treatment ivermectin and other drugs for off-label uses as COVID-19 treatments.
The bill goes next to the full Senate for debate. The Republican majority there also is considering a proposal to greatly limit the power of the state’s public health administrator to deal with infectious diseases and another to ban all mask mandates during future pandemics.
“When you put them all together, it’s a lot of negative bills,” said Democratic Sen. Cindy Holscher, of Overland Park.
The measure approved Thursday would require schools to grant an exemption to parents who say vaccinations violate their religious or strongly held moral or ethical beliefs without investigating those beliefs.
A law enacted in November granted a similar, broad exemption to workers seeking to avoid COVID-19 vaccine mandates.
“It allows the day care-aged kids’ parents and school-aged kids’ parents to enjoy the same freedom of religion that everyone else would,” said Sen. Mark Steffen, a Hutchinson Republican.
But Sen. Kristen O’Shea, of Topeka, broke with fellow Republicans in opposing the measure and noted Thursday that the committee didn’t have a hearing on weakening childhood vaccination requirements.
She said during a meeting earlier this month: “It’s really scary to think that we’re in a society that’s going to bring back measles and polio and whooping cough, et cetera.”
The committee approved a version of the bill early last month, but it became tangled in a dispute over congressional redistricting that involved Steffen. Senate President Ty Masterson, an Andover Republican, sent it back to the committee for what a spokesperson called “some tweaks.”
The measure also is shadowed by a state medical board investigation of Steffen, an anesthesiologist and pain-management specialist from Hutchinson. While Steffen disclosed the investigation and acknowledged trying to prescribe ivermectin, he has said the probe deals with his public statements about COVID-19 and not patient care.
Steffen pushed the previous version of the bill, which would have required pharmacists to fill all prescriptions of drugs for off-label uses in treating COVID-19. Kansas law allows pharmacists not to fill prescriptions they deem inappropriate or potentially harmful.
The U.S. Food and Drug Administration has approved ivermectin to treat infections of lice, roundworms and other tiny parasites in humans. The FDA has tried to debunk claims that animal-strength versions of the drug can help fight COVID-19, warning that large doses can cause nausea, vomiting, diarrhea, seizures, delirium and even death.
The new version of the bill says pharmacists still can refuse to fill drugs for off-label COVID-19 treatments, unless they object only because it’s for treating the novel coronavirus.
The measure prohibits the state medical board from disciplining doctors over such prescriptions, but the committee dropped a provision that would have made that ban apply at the start of the coronavirus pandemic in March 2020.
Steffen said Thursday that he believes doctors who prescribe ivermectin and other drugs to treat COVID-19 can show that they’re doing what other reasonable physicians would do in similar circumstances. That’s the standard the state medical board uses to determine whether a doctor is providing adequate care.

Source: Voice of America